Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.

Position in JANX — Janux Therapeutics, Inc.

CIK 2011081 WARSZAWA, R9

Back to JANX Full portfolio

Position in JANX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$5,233,294

+$37,650 QoQ

Shares Held

376,496

0.0% QoQ

Ownership

0.617%

of shares outstanding

% of Portfolio

0.50%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in JANX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds $261,074,012 across 8 Biotechnology names. JANX ranks #7 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	765,915	$85,284,635
2	PTGX	Protagonist Therapeutics, Inc	571,825	$60,270,355
3	RVMD	Revolution Medicines, Inc.	479,080	$46,590,530
4	CYTK	Cytokinetics Inc	660,310	$43,521,032
5	NKTR	Nektar Therapeutics	122,326	$8,801,355
6	QURE	uniQure N.V.	521,677	$8,529,418
7	JANX	Janux Therapeutics, Inc. This page	376,496	$5,233,294
8	MLYS	Mineralys Therapeutics, Inc.	104,961	$2,843,393

All Filings in JANX

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,233,294	376,496	0.0%	Shares	Sole	2026-05-12
2025-12-31	$5,195,644	376,496	0.0%	Shares	Sole	2026-02-11
2025-09-30	$9,201,562	376,496	0.0%	Shares	Sole	2025-11-12
2025-06-30	$8,697,057	376,496	0.0%	Shares	Sole	2025-07-25
2025-03-31	$10,165,392	376,496	-12.3%	Shares	Sole	2025-05-06
2024-12-31	$22,989,647	429,392	-9.0%	Shares	Sole	2025-02-18
2024-09-30	$21,430,966	471,736	—	Shares	Sole	2024-10-21
No filing history on record for this holder in this stock.